HIGHLIGHTS
- who: Report and colleagues from the (UNIVERSITY) have published the research work: Review began 03/06/2023 Review ended 03/15/2023 Published 03/19/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/19,/2023
- what: The aim is to resect the tumor with negative microscopic margins.
- future: Study is needed to understand the recurrence after imatinib therapy and the metastasis of the disease.
SUMMARY
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal system, which, in most cases, are KIT (CD117) positive. This type of tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.